The FDA’s restraints on food ingredients are limited and relatively feeble, especially compared with those in Europe, a KFF Health News examination found. There are at least 950 substances in our food that are not permitted in Europe, according to one expert’s estimate, and chemicals linked to health concerns show up in hundreds of products that line the shelves of American supermarkets.

Research shows that financial relationships with drug companies impacts decision-making in ways that benefit drug companies, including altering prescribing habits.

She left the agency in January, She's already CMO of Pfizer

Internal emails show that the US Food and Drug Administration informs employees leaving for industry jobs that, despite restrictions on post-employment lobbying, they are still permitted to influence the agency.

British Medical Journal Investigates Legal Corruption by FDA

When the Food and Drug Administration recently convened a committee of advisers to assess a cardiac device made by Abbott, the agency didn’t disclose that most of them had received payments from the company or conducted research it had funded — information readily available in a federal database.

Is the FDA secretly funding non-profits to lobby? When the agency would not honor a FOIA request last summer for this basic information, Protect the Public’s Trust (PPT) was forced to take the FDA to court. Seven months later, our wait continues.

"There needs to be a fix for the drug preclusion clause that works against wider, low-cost access to highly effective dietary supplements like NMN," he said in an email. "We can't let pharmaceutical companies keep gaining monopolies on vital, natural ingredients Americans need to improve their health."

As pharma companies underwrite three-fourths of the FDA’s budget for scientific reviews, the agency is increasingly fast-tracking expensive drugs with significant side effects and unproven health benefits.

Here’s why drug prices are so high.

To fully grasp drugmakers’ vehement pushback on any attempts to reduce drug prices, it’s important to pull back the curtain on the industry’s ongoing anti-competitive practices to see what else is really at stake. Patent monopolies on 7 out of 10 of America’s top selling drugs should expire this decade.

At a congressional hearing, McKinsey executives testified that working for both the FDA and the manufacturer of OxyContin did not create a conflict of interest.

Our healthcare system is broken, a fact nobody would have disputed in precovid days. Regulatory capture is a reality, and the pharmaceutical industry is fraught with examples. Yet we trusted private-public partnerships to find an optimal solution to a global pandemic, assuming a crisis would bring out the best in historically corrupt institutions.

The startling price hike was precipitated by a well-intentioned federal government program, called the Unapproved Drugs Initiative, that created unforeseen consequences. It was supposed to protect the public by ensuring that older drugs went through a Food and Drug Administration approval process to determine their safety and efficacy and that older versions were taken off the market.

In further researching the matter, I encountered numerous reports of similar past instances, but nowhere were they better analyzed and summarized than in the 2018 book Death by Regulation: How We Were Robbed of a Golden Age of Health and How We Can Reclaim It. Written by former Upjohn research scientist Dr. Mary Ruwart, the book is a comprehensive — and frankly shocking — indictment of a federal bureaucracy gone mad.

Pharma-giant Pfizer announced on June 28 that the former US Food and Drug Administration commissioner Scott Gottlieb would be joining its board of directors.

Scott Gottlieb, who stepped down as Food and Drug Administration Commissioner in April, will join Pfizer ’s board of directors, the company announced Thursday.

More than 40 states say the biggest drug makers engaged in “industry-wide conspiracy” to fix prices of generic drugs

According to a new lawsuit, generic medications including oral antibiotics, blood thinners, cancer drugs, contraceptives and H.I.V. treatments were subject to unlawful price fixing.

The Food and Drug Administration has let companies file reports of injuries and malfunctions outside a widely scrutinized public database.

Despite the ongoing opioid crisis plaguing the nation, the US Food and Drug Administration on Friday approved a new opioid medication five to 10 times more powerful than fentanyl.

Science investigation of journal disclosures and pharmaceutical funding records shows potential influence on physician gatekeepers

Makers of brand-name drugs called out by the Trump administration for potentially stalling generic competition have hiked their prices by double-digit percentages since 2012 and cost Medicare and Medicaid nearly $12 billion in 2016, a Kaiser Health News analysis has found.

New reports reveal 300,000 Americans have died of overdoses since the FDA approved semi-synthetic opioid drugs like OxyContin®. Find out the FDA’s insidious role in approving these addicting drugs for routine pain relief and better ways to address inflammation and pain signals received by the brain.

Elvis Gordon, a U.S. Food and Drug Administration (“FDA”) supervisor, and small business owner Ivan Ponder have been arraigned on bribery and conspiracy charges for using Gordon’s influence to divert FDA contracts to a company owned by Ponder.

Last week, the Food and Drug Administration announced that a drug previously not officially available to patients in the United States had been approved. Deflazacort, a corticosteroid, has been shown to be useful and life-prolonging for patients with Duchenne muscular dystrophy, a rare and fatal disease... The drug will be marketed under the name Emflaza, and its sticker price will be $89,000 for a year’s worth of pills.

Two hedge fund managers and a consultant were charged Wednesday for allegedly making about $32 million through insider trades based on confidential information obtained from the FDA, and a fourth person was charged in a related case.

Manhattan hedge fund manager was charged on Wednesday with trading on confidential tips about drug approvals, in one of the biggest insider trading cases since a 2014 court ruling made it harder for U.S. prosecutors to pursue them.

In Britain the world's 20 top-selling medicines are three times cheaper than in the U.S.

In at least 57 clinical trials conducted from 1998 to 2013, the US Food and Drug Administration found evidence of falsification, problems with reporting side-effects, inadequate record-keeping, and more. But only three of the resulting 78 publications monitored in today's report mentioned the misconduct uncovered during inspections. And no corrections, retractions, or other comments were added after publication.

The FDA buries evidence of fraud in medical trials.

Some spectacular jumps in generic drug prices have been exposed in an article in the New England Journal of Medicine. Doxycycline, an antibiotic, went from $.06 a pill to$3.36, an increase of more than 5,000 percent. Captopril, used for hypertension, increased 2,800 percent.

Despite data showing that Trasylol® inflicted severe kidney damage in animals,6 the FDA approved it for human use in 1993. Low-cost alternative anti-bleeding drugs are less likely to produce this lethal side effect.

For the past four decades, Life Extension® has warned that corrupt legislation and suffocating FDA regulation will bankrupt the United States. That day of reckoning is approaching as the government is rapidly losing the ability to subsidize the economically unsustainable healthcare costs it has created. Here we detail how inefficient and fraudulent government edicts have led to today’s disease-care crisis—and how this catastrophe can be averted with commonsense changes to the law.

As the population of the United States ages, the government-run Medicare program is becoming increasingly unsustainable. For years, Life Extension® has battled against the inflated costs and outright fraud plaguing this bloated bureaucracy. Radical changes are the only solution to correct this ongoing tragedy of inefficient and ineffective healthcare.

Today’s health care cost crisis is widely feared. In a shocking expose, Life Extension uncovers a corrupt regulatory system that causes generic drug prices to be far higher than they should be. A free market solution is proposed that can save consumers up to 94% on generic drugs, slashing prices in some cases to only pennies a day!

Congress frequently circulates legislation that provides greater power to the pharmaceutical industry, while penalizing those who offer alternatives to expensive prescription drugs. Find out how to fight back against special interests that seek to destroy free market competition.

As demonstrated by the Vioxx® scandal and skyrocketing drug prices, consumers are being defrauded out of their health and money by a bureaucracy that long ago outlived its usefulness.

Drug companies spent millions of dollars on Capitol Hill to pass the new Medicare bill that leaves taxpayers holding the bag and denies Americans legal access to lower-cost medications from Canada. But this war’s just begun—with drug prices soaring, local and state officials have begun to fight back.

At the end of this article, we are going to publish shocking information that has never been divulged to the public. For the benefit of new members, however, we will first provide a brief historical overview.

The FDA wants you brain dead. Here's how they're going about it.